Terms: = Kidney tumors AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
110 results:
1. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.
Falagario UG; Abbadi A; Remmers S; Björnebo L; Bogdanovic D; Martini A; Valdman A; Carrieri G; Menon M; Akre O; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
JAMA Netw Open; 2023 Sep; 6(9):e2332900. PubMed ID: 37695584
[TBL] [Abstract] [Full Text] [Related]
2. Optimization of cardiovascular risk factor management in patients with bcr::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives.
Krecak I; Verstovsek S; Lucijanic M
Ann Hematol; 2024 May; 103(5):1513-1523. PubMed ID: 37665349
[TBL] [Abstract] [Full Text] [Related]
3. Enhancing information on stage at diagnosis for childhood cancer in Africa.
Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
[TBL] [Abstract] [Full Text] [Related]
4. Acute kidney injury in children with haematological malignancy: a territory-wide study.
Lam SY; Chan EY; Cheng FWT; Ma ALT; Ha SY
Pediatr Nephrol; 2023 Nov; 38(11):3823-3833. PubMed ID: 37219640
[TBL] [Abstract] [Full Text] [Related]
5. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
6. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.
Zhai T; Dou M; Ma Y; Wang H; Liu F; Zhang L; Chong T; Wang Z; Xue L
Lipids Health Dis; 2023 Mar; 22(1):39. PubMed ID: 36915125
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis.
Bai H; Jiang W; Wang D; Shou J; Li C; Xing N
BMC Urol; 2022 Aug; 22(1):135. PubMed ID: 36038864
[TBL] [Abstract] [Full Text] [Related]
8. [Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma].
Qin CP; Song YX; Ding MT; Wang F; Lin JX; Yang WB; DU YQ; Li Q; Liu SJ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):663-668. PubMed ID: 35950389
[TBL] [Abstract] [Full Text] [Related]
9. Towards zero percent treatment abandonment of patients with common and curable childhood cancer types in Blantyre, Malawi.
Chakumatha E; Khofi H; Landman L; Weijers J; Bailey S; Chagaluka G; Molyneux E; Israels T
Pediatr Blood Cancer; 2022 Dec; 69(12):e29899. PubMed ID: 35869892
[TBL] [Abstract] [Full Text] [Related]
10. The tricks for fighting against cancer using CAR NK cells: A review.
Vahidian F; Khosroshahi LM; Akbarzadeh M; Jahanban-Esfahlan A; Baghbanzadeh A; Ali-Hassanzadeh M; Safarzadeh E
Mol Cell Probes; 2022 Jun; 63():101817. PubMed ID: 35436564
[TBL] [Abstract] [Full Text] [Related]
11. PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer.
Crocerossa F; Carbonara U; Parekh J; Urdaneta A; Weprin S; Damiano R; Grob MB; Hampton LJ; Paul A; Autorino R; Cantiello F
Urol Int; 2022; 106(9):920-927. PubMed ID: 34933313
[TBL] [Abstract] [Full Text] [Related]
12. Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials.
Mo DC; Huang JF; Luo PH; Huang SX; Wang HL
Clin Immunol; 2021 Nov; 232():108876. PubMed ID: 34740840
[TBL] [Abstract] [Full Text] [Related]
13. treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries.
Doshi JA; Jahnke J; Raman S; Puckett JT; Brown VT; Ward MA; Li P; Manz CR
J Manag Care Spec Pharm; 2021 Oct; 27(10):1457-1468. PubMed ID: 34595957
[No Abstract] [Full Text] [Related]
14. Assessment of oncological and functional outcomes of retropubic radical prostatectomy: An academic center experience.
Prudhomme T; Roumiguié M; Péricart S; Doumerc N; Lesourd M; Patard PM; Gamé X; Soulié M; Thoulouzan M
Prog Urol; 2021 Dec; 31(16):1123-1132. PubMed ID: 34565670
[TBL] [Abstract] [Full Text] [Related]
15. Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 tumors-A Nationwide Experience.
Blanc T; Meignan P; Vinit N; Ballouhey Q; Pio L; Capito C; Harte C; Vatta F; Galmiche-Rolland L; Minard V; Orbach D; Berteloot L; Muller C; Kohaut J; Broch A; Braik K; Binet A; Heloury Y; Fourcade L; Lardy H; Sarnacki S
Ann Surg Oncol; 2022 Feb; 29(2):1315-1326. PubMed ID: 34523002
[TBL] [Abstract] [Full Text] [Related]
16. Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial.
Murphy CC; Fullington HM; Gerber DE; Bowman IA; Puligandla M; Dutcher JP; DiPaola RS; Haas NB
Cancer Med; 2021 Sep; 10(17):5917-5924. PubMed ID: 34405965
[TBL] [Abstract] [Full Text] [Related]
17. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.
Philipson RG; Romero T; Wong JK; Stish BJ; Dess RT; Spratt DE; Pilar A; Reddy C; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Braccioforte M; Tran PT; Martin S; Martinez-Monge R; Krauss DJ; Abu-Isa EI; Valle L; Chong N; Pisansky TM; Choo CR; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Tilki D; Karnes RJ; Klein EA; Tosoian JJ; Boutros PC; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Kupelian PA; Rettig MB; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Horwitz EM; Tendulkar RD; Kishan AU
Eur Urol; 2021 Aug; 80(2):142-146. PubMed ID: 33985797
[TBL] [Abstract] [Full Text] [Related]
18. Robot-assisted radical prostatectomy versus standard laparoscopic radical prostatectomy: an evidence-based analysis of comparative outcomes.
Carbonara U; Srinath M; Crocerossa F; Ferro M; Cantiello F; Lucarelli G; Porpiglia F; Battaglia M; Ditonno P; Autorino R
World J Urol; 2021 Oct; 39(10):3721-3732. PubMed ID: 33843016
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial.
Powles T; Atkins MB; Escudier B; Motzer RJ; Rini BI; Fong L; Joseph RW; Pal SK; Sznol M; Hainsworth J; Stadler WM; Hutson TE; Ravaud A; Bracarda S; Suarez C; Choueiri TK; Reeves J; Cohn A; Ding B; Leng N; Hashimoto K; Huseni M; Schiff C; McDermott DF
Eur Urol; 2021 May; 79(5):665-673. PubMed ID: 33678522
[TBL] [Abstract] [Full Text] [Related]
20. Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies.
Hoseini SS; Espinosa-Cotton M; Guo HF; Cheung NV
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33239418
[TBL] [Abstract] [Full Text] [Related]
[Next]
